Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | TUBGCP5 | Human | (-)-demecolcine | decreases expression | EXP | | 6480464 | Demecolcine results in decreased expression of TUBGCP5 mRNA | CTD | PMID:23649840 | TUBGCP5 | Human | (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TUBGCP5 mRNA | CTD | PMID:22079256 | TUBGCP5 | Human | 1,2-dimethylhydrazine | decreases expression | ISO | Tubgcp5 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of TUBGCP5 mRNA | CTD | PMID:22206623 | TUBGCP5 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Tubgcp5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TUBGCP5 mRNA | CTD | PMID:21354282 | TUBGCP5 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Tubgcp5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of TUBGCP5 mRNA | CTD | PMID:24680724 | TUBGCP5 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of TUBGCP5 mRNA | CTD | PMID:22574217 | TUBGCP5 | Human | 2,6-dinitrotoluene | affects expression | ISO | Tubgcp5 (Rattus norvegicus) | 6480464 | 2 and 6-dinitrotoluene affects the expression of TUBGCP5 mRNA | CTD | PMID:21346803 | TUBGCP5 | Human | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Tubgcp5 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of TUBGCP5 mRNA | CTD | PMID:26251327 | TUBGCP5 | Human | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TUBGCP5 mRNA | CTD | PMID:28628672 | TUBGCP5 | Human | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of TUBGCP5 mRNA | CTD | PMID:32763439 | TUBGCP5 | Human | aflatoxin B1 | increases expression | ISO | Tubgcp5 (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of TUBGCP5 mRNA | CTD | PMID:19770486 | TUBGCP5 | Human | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of TUBGCP5 mRNA | CTD | PMID:33167477 | TUBGCP5 | Human | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of TUBGCP5 mRNA and aristolochic acid I results in decreased expression of TUBGCP5 protein | CTD | PMID:33212167 | TUBGCP5 | Human | Benoxacor | decreases expression | ISO | Tubgcp5 (Mus musculus) | 6480464 | benoxacor results in decreased expression of TUBGCP5 mRNA | CTD | PMID:34850242 | TUBGCP5 | Human | bisphenol A | decreases expression | ISO | Tubgcp5 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of TUBGCP5 mRNA | CTD | PMID:30816183 and PMID:34947998 | TUBGCP5 | Human | bisphenol F | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TUBGCP5 mRNA | CTD | PMID:28628672 | TUBGCP5 | Human | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of TUBGCP5 mRNA | CTD | PMID:38568856 | TUBGCP5 | Human | choline | multiple interactions | ISO | Tubgcp5 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TUBGCP5 gene | CTD | PMID:20938992 | TUBGCP5 | Human | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of TUBGCP5 mRNA | CTD | PMID:19376846 | TUBGCP5 | Human | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of TUBGCP5 mRNA | CTD | PMID:19549813 | TUBGCP5 | Human | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of TUBGCP5 mRNA | CTD | PMID:25562108 | TUBGCP5 | Human | DDE | increases expression | EXP | | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased expression of TUBGCP5 mRNA | CTD | PMID:38568856 | TUBGCP5 | Human | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TUBGCP5 mRNA | CTD | PMID:28628672 | TUBGCP5 | Human | folic acid | multiple interactions | ISO | Tubgcp5 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TUBGCP5 gene | CTD | PMID:20938992 | TUBGCP5 | Human | gentamycin | decreases expression | ISO | Tubgcp5 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of TUBGCP5 mRNA | CTD | PMID:33387578 | TUBGCP5 | Human | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TUBGCP5 mRNA | CTD | PMID:28628672 | TUBGCP5 | Human | L-methionine | multiple interactions | ISO | Tubgcp5 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TUBGCP5 gene | CTD | PMID:20938992 | TUBGCP5 | Human | methyl methanesulfonate | increases expression | EXP | | 6480464 | Methyl Methanesulfonate results in increased expression of TUBGCP5 mRNA | CTD | PMID:23649840 | TUBGCP5 | Human | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of TUBGCP5 mRNA | CTD | PMID:21420995 | TUBGCP5 | Human | potassium chromate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TUBGCP5 mRNA | CTD | PMID:22079256 | TUBGCP5 | Human | potassium chromate | decreases expression | EXP | | 6480464 | potassium chromate(VI) results in decreased expression of TUBGCP5 mRNA | CTD | PMID:22079256 | TUBGCP5 | Human | rotenone | affects expression | ISO | Tubgcp5 (Mus musculus) | 6480464 | Rotenone affects the expression of TUBGCP5 mRNA | CTD | PMID:21893155 | TUBGCP5 | Human | rotenone | multiple interactions | ISO | Tubgcp5 (Mus musculus) | 6480464 | TRP53 affects the reaction [Rotenone affects the expression of TUBGCP5 mRNA] | CTD | PMID:21893155 | TUBGCP5 | Human | sodium arsenate | increases expression | ISO | Tubgcp5 (Mus musculus) | 6480464 | sodium arsenate results in increased expression of TUBGCP5 mRNA | CTD | PMID:21795629 | TUBGCP5 | Human | sodium arsenite | increases expression | ISO | Tubgcp5 (Rattus norvegicus) | 6480464 | sodium arsenite results in increased expression of TUBGCP5 mRNA | CTD | PMID:21297353 | TUBGCP5 | Human | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of TUBGCP5 mRNA | CTD | PMID:34032870 | TUBGCP5 | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of TUBGCP5 mRNA | CTD | PMID:38568856 | TUBGCP5 | Human | sodium fluoride | increases expression | ISO | Tubgcp5 (Mus musculus) | 6480464 | Sodium Fluoride results in increased expression of TUBGCP5 mRNA | CTD | PMID:27862939 | TUBGCP5 | Human | thiram | decreases expression | EXP | | 6480464 | Thiram results in decreased expression of TUBGCP5 mRNA | CTD | PMID:38568856 | TUBGCP5 | Human | titanium dioxide | decreases methylation | ISO | Tubgcp5 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of TUBGCP5 promoter | CTD | PMID:35295148 | TUBGCP5 | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of TUBGCP5 mRNA | CTD | PMID:37042841 | TUBGCP5 | Human | vincristine | decreases expression | EXP | | 6480464 | Vincristine results in decreased expression of TUBGCP5 mRNA | CTD | PMID:23649840 | |